109 related articles for article (PubMed ID: 22705296)
1. Clinical factors influencing corrected count increment.
Shastry S; Chaudhary R
Transfus Apher Sci; 2012 Dec; 47(3):327-30. PubMed ID: 22705296
[TBL] [Abstract][Full Text] [Related]
2. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
Cid J; Ramiro L; Escoda L; Llorente A
Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on the effectiveness in 727 times of platelet transfusion].
Gui R; Nie XM; Wen XH; Liu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):381-5. PubMed ID: 22541103
[TBL] [Abstract][Full Text] [Related]
5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
[TBL] [Abstract][Full Text] [Related]
7. The effects of infusion methods on platelet count, morphology, and corrected count increment in children with cancer: in vitro and in vivo studies.
Norville R; Hinds P; Wilimas J; Fairclough D; Fischl S; Kunkel K
Oncol Nurs Forum; 1994; 21(10):1669-73. PubMed ID: 7854929
[TBL] [Abstract][Full Text] [Related]
8. Estimation and predictive use of the corrected count increment--a proposed clinical guideline.
Wood L; Jogessar V; Ward P; Jacobs P
Transfus Apher Sci; 2005 Feb; 32(1):117-24. PubMed ID: 15737880
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-yield thrombocytapheresis on the quality of platelet products.
Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
[TBL] [Abstract][Full Text] [Related]
10. The impact of apheresis platelet manipulation on corrected count increment.
Karafin M; Fuller AK; Savage WJ; King KE; Ness PM; Tobian AA
Transfusion; 2012 Jun; 52(6):1221-7. PubMed ID: 22233358
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
[TBL] [Abstract][Full Text] [Related]
12. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.
Lozano M; Knutson F; Tardivel R; Cid J; Maymó RM; Löf H; Roddie H; Pelly J; Docherty A; Sherman C; Lin L; Propst M; Corash L; Prowse C
Br J Haematol; 2011 May; 153(3):393-401. PubMed ID: 21418180
[TBL] [Abstract][Full Text] [Related]
13. The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation.
Li G; Liu F; Mao X; Hu L
Transfus Apher Sci; 2011 Aug; 45(1):21-4. PubMed ID: 21798807
[TBL] [Abstract][Full Text] [Related]
14. Platelet corrected count increments by apheresis platform.
Tobian AA; King KE; Borge PD; Fuller AK; Uglik K; Ness PM
Transfusion; 2016 Oct; 56(10):2584-2586. PubMed ID: 27572682
[TBL] [Abstract][Full Text] [Related]
15. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
[TBL] [Abstract][Full Text] [Related]
16. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
Cameron B; Rock G; Olberg B; Neurath D
Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
[TBL] [Abstract][Full Text] [Related]
18. Preparation of random donor leukocyte-poor platelets by cytapheresis.
Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
[TBL] [Abstract][Full Text] [Related]
19. Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients.
Schlenke P; Hagenah W; Irsch J; Sundin D; Corash L; Lin L; Kirchner H; Wagner T
Ann Hematol; 2011 Dec; 90(12):1457-65. PubMed ID: 21503644
[TBL] [Abstract][Full Text] [Related]
20. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
